KEGG   DRUG: TasonerminHelp
Entry
D08562                      Drug                                   

Name
Tasonermin (INN);
Beromun (TN)
Formula
C778H1225N215O231S2
Exact mass
17340.016
Mol weight
17350.483
Remark
ATC code: L03AX11
Efficacy
Antineoplastic
Comment
recombinant human TNF-alpha [HSA:7124] [KO:K03156]
Target
TNFRSF1 (CD120) [HSA:7132 7133] [KO:K03158 K05141]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04064  NF-kappa B signaling pathway
hsa04668  TNF signaling pathway
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L03 IMMUNOSTIMULANTS
   L03A IMMUNOSTIMULANTS
    L03AX Other immunostimulants
     L03AX11 Tasonermin
      D08562  Tasonermin (INN)
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   Tumor necrosis factor receptors
    TNFRSF1 (CD120)
     D08562  Tasonermin (INN)
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D08562
BRITE hierarchy
Other DBs
CAS: 94948-59-1
PubChem: 96025247
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system